Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
Read More

Higher Interest Rates, The Fed and Getting Back on the (S)ARK

St. Louis Federal Reserve President James Bullard expressed confidence that the Fed can beat inflation and advocated for a more aggressive interest rate hike to combat it. Bullard believes that a more aggressive move now would give the Federal Open Market Committee a better chance to bring down inflation, which is still high despite falling from its levels in 2022.


Read More

Takeda Earlier Announced Results from Phase 3 Study of Vedolizumab for Prevention of Intestinal Acute Graft-Versus-Host Disease in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

The Phase 3 GRAPHITE Study Met Its Primary Efficacy Endpoint of Significant and Clinically Meaningful Intestinal aGvHD-Free Survival as Compared to Placebo by Day 180 after Allo-HSCT. No New Safety Signals Were Seen